Habib Belaid, founder of Kervalion, a company developing an innovative 3D-printed bone graft solution for dental surgeons, talks about his experience with Strategic ChallengeEurobiomed's support offering, which combines the expertise of its team with that of its network.
How did the initial phase of qualifying your needs with Eurobiomed go?
The first stage was crucial, and involved drawing up precise specifications. We develop medical devices for dental surgery, and it was essential to clearly define our needs in terms of both European and American regulations.
Eurobiomed supported us in this phase to ensure that the service providers we would be calling upon corresponded exactly to our sector of activity and our specific issues.
How did Eurobiomed's support make your process easier?
We saved a considerable amount of time. Without the support of Eurobiomed, we would have had to do all the work of benchmarking the consulting firms ourselves, then challenge them one by one.
Eurobiomed's expertise in selecting service providers gave us direct access to qualified firms relevant to our project. This approach saved us several weeks in our selection process.
What concrete impact has this had on your business strategy?
This collaboration has provided us with essential certainties for our development. Thanks to Strategic Challenge, we were able to precisely define the class of our medical device and identify the standards applicable to it.
We also gained a clear vision of the timescales and costs associated with our regulatory development. This first phase served as a real springboard for the rest of our regulatory development.
